Literature DB >> 23375557

Mental disorders and smoking trajectories: a 10-year prospective study among adolescents and young adults in the community.

Renee D Goodwin1, Axel Perkonigg, Michael Höfler, Hans Ulrich Wittchen.   

Abstract

BACKGROUND: Numerous studies have documented an association between mental disorders and onset of cigarette smoking. Yet, there is little understanding of the potential impact of mental disorders on trajectories of smoking over time. The objective of this study was to investigate this relationship among adolescents over a 10-year span.
METHODS: Data were drawn from the Early Developmental Stages of Psychopathology Study, a 10-year prospective investigation of youth in Germany. Growth mixture modeling was used to identify smoking trajectories and logistic regression analyses were used to examine relationships between mental disorders and subsequent trajectories.
RESULTS: Four trajectories were identified: non-users; increasing use; decreasing use; persistent use. Alcohol/drug use disorders, stress disorders, anxiety disorders, somatoform disorder and nicotine dependence were associated with nicotine use (as compared to the non-smoker class). However, comparisons between trajectories of nicotine use showed that any stress disorder predicted only decreasing use compared to the other two trajectories; nicotine dependence, alcohol/illicit drug use disorders as well as panic disorder and somatoform disorders were inversely associated with increasing use; nicotine dependence and alcohol/drug use disorders were associated with persistent use.
CONCLUSIONS: Several mental disorders appear to be non-specific markers of the range of smoking trajectories while others predict specific trajectories. Numerous disorders (e.g., alcohol/drug use disorders) do not appear to occur only prior to and predict increased smoking trajectory as had been previously suggested, but rather they also occur concurrently, with high levels of smoking and in some cases smoking persists at a steady level over time.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23375557     DOI: 10.1016/j.drugalcdep.2012.11.009

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  6 in total

Review 1.  The 'Early Developmental Stages of Psychopathology (EDSP) study': a 20-year review of methods and findings.

Authors:  Katja Beesdo-Baum; Susanne Knappe; Eva Asselmann; Petra Zimmermann; Tanja Brückl; Michael Höfler; Silke Behrendt; Roselind Lieb; Hans-Ulrich Wittchen
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-05-16       Impact factor: 4.328

Review 2.  Investigating the reciprocal temporal relationships between tobacco consumption and psychological disorders for youth: an international review.

Authors:  Jeremy Stevenson; Caroline Louise Miller; Kimberley Martin; Leila Mohammadi; Sharon Lawn
Journal:  BMJ Open       Date:  2022-06-13       Impact factor: 3.006

Review 3.  Annual research review: Optimal outcomes of child and adolescent mental illness.

Authors:  E Jane Costello; Barbara Maughan
Journal:  J Child Psychol Psychiatry       Date:  2014-12-12       Impact factor: 8.982

4.  Changes in the prevalence of mood and anxiety disorders among male and female current smokers in the United States: 1990-2001.

Authors:  Renee D Goodwin; Melanie M Wall; Tse Choo; Sandro Galea; Jonathan Horowitz; Yoko Nomura; Michael J Zvolensky; Deborah S Hasin
Journal:  Ann Epidemiol       Date:  2014-04-28       Impact factor: 3.797

Review 5.  A review of epidemiologic research on smoking behavior among persons with alcohol and illicit substance use disorders.

Authors:  Andrea H Weinberger; Allison P Funk; Renee D Goodwin
Journal:  Prev Med       Date:  2016-05-16       Impact factor: 4.018

6.  Frontal Cortex Transcriptome Analysis of Mice Exposed to Electronic Cigarettes During Early Life Stages.

Authors:  Dana E Lauterstein; Pamella B Tijerina; Kevin Corbett; Betul Akgol Oksuz; Steven S Shen; Terry Gordon; Catherine B Klein; Judith T Zelikoff
Journal:  Int J Environ Res Public Health       Date:  2016-04-12       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.